The estimated Net Worth of Nancy Lynn Md Snyderman is at least $846 millier dollars as of 29 June 2024. Nancy Snyderman owns over 6,104 units of Axonics Inc stock worth over $419,528 and over the last 8 years he sold AXNX stock worth over $0. In addition, he makes $426,450 as Independent Director at Axonics Inc.
Nancy has made over 8 trades of the Axonics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,104 units of AXNX stock worth $419,528 on 29 June 2024.
The largest trade he's ever made was exercising 7,585 units of Axonics Inc stock on 14 June 2022 worth over $521,317. On average, Nancy trades about 1,199 units every 63 days since 2016. As of 29 June 2024 he still owns at least 6,104 units of Axonics Inc stock.
You can see the complete history of Nancy Snyderman stock trades at the bottom of the page.
Dr. Nancy Lynn Snyderman M.D. serves as Independent Director of the Company. Dr. Snyderman has served as an independent director on the board of directors of Alkermes plc (NASDAQ: ALKS) and as a member of the nominating and corporate governance committee since 2016. Dr. Snyderman was an advisory board member to GE’s Healthymagination for twelve years and previously served as a vice president for corporate communications at Johnson & Johnson. Dr. Snyderman is a board-certified head and neck surgeon and has had academic appointments at the University of Pennsylvania and the University of California-San Francisco. She recently served as a professor at the Center for Innovation for Global Health at Stanford University. Dr. Snyderman is an Emmy award winning medical correspondent having worked at ABC News from 1987 to 2003 and later as chief medical editor at NBC News from 2004 to 2015. She has been widely published in peer-reviewed medical journals and has written for Good Housekeeping, AARP, Parenting, Health, and O magazines. Dr. Snyderman is an advocate for women’s health and a prolific public speaker and presently serves on the board of directors of Fair Food Network and the Albright Institute at Wellesley College. Dr. Snyderman holds a B.A. in microbiology from Indiana University and a M.D. from the University of Nebraska and has completed residencies in Pediatrics and Otolaryngology Head and Neck Surgery at the University of Pittsburgh. Snyderman’s extensive experience as a physician, advisor for, and director of medical device companies qualifies her to serve on our Board.
As the Independent Director of Axonics Inc, the total compensation of Nancy Snyderman at Axonics Inc is $426,450. There are 13 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.
Nancy Snyderman is 68, he's been the Independent Director of Axonics Inc since 2019. There are no older and 21 younger executives at Axonics Inc.
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik et Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: